The Market for Minimally Invasive Medical Devices

Report Code: HLC051J

Publish Date: Aug 2023

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.

Report Includes

  • 21 data tables and 26 additional tables
  • An up-to-date overview and industry analysis of the global markets for minimally invasive medical surgical devices and instruments within the industry
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the current market size and revenue growth forecast for the global minimally invasive medical devices market in USD million values, and corresponding market share analysis based on equipment type, application, end user, and region
  • Identification of the segments of main types of minimally invasive devices and instruments that have been commercialized till date
  • Analysis of historical and current volume and value of shipments of each of these product segments in specified end user and geographic markets
  • Updated information on key market drivers and opportunities, industry shifts and regulations, and other region and industry specific macroeconomic variables that will influence this market in the coming years (2023-2028)
  • Identification of promising new surgical procedures and products still in the development and testing stage and assess their probability of successful commercialization in the next 5 years
  • A look at the leading device manufacturers and analyze the structure of the minimally invasive surgical devices industry (e.g., market shares, concentration and recent merger and acquisition (M&A) activity)
  • Discussion of the current state of minimally invasive medical surgical devices and instruments, commercialized and pipeline products, regulations and standards, as well as key industry aspects
  • Review of the key patent grants and patent applications on minimally invasive medical surgical devices and instruments
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the leading global players of the industry, including 3M, Abbott, Danaher Corp., Johnson & Johnson and Olympus Corp.

Report Scope

This report on minimally invasive medical devices is segmented based on equipment types, application types and end users.

A detailed analysis illustrating market dynamics and market structure is incorporated in the report. A Porter’s Five Forces analysis and the supply and distribution chain are discussed in detail for an in-depth market understanding. The report covers the current regulations and guidelines for minimally invasive medical devices. The report includes top market players detailing their business operations, segment focus, revenue, and strategy analysis. Market share analysis of leading market players, product launches, and pipeline products are also captured in the information.

Regarding geography, the reports analyze the market across North America, Europe, and Asia-Pacific. Key countries like the U.S., Canada, Mexico, Europe (top five countries), China, India, and Japan are discussed due to the high concentration of minimally invasive medical device manufacturing companies and contract manufacturing organizations in these countries.

The base year for market data is 2022, with historical data for 2020 and forecast data for 2028. Historical, base year and forecast data are provided for each market segment of the report.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $26.4 billion
Market size forecast $41.0 billion
Growth rate CAGR of 7.6%
Units considered $ Millions
Segments covered equipment type, application, and end user
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Key Market Drivers
  • Increasing Prevalence of Surgery
  • Increase in Minimally Invasive Surgeries
  • Increasing Expenditures for Healthcare
  • Increasing Geriatric Population
Companies studied
3MABBOTT
B. Braun SEBAXTER
BDBIO-RAD LABORATORIES INC.
BOSTON SCIENTIFIC CORP.CARDINAL HEALTH
DANAHER CORP.DRAGERWERK AG & CO. KGAA
F. HOFFMANN-LA ROCHE LTD.INTEGRA LIFESCIENCES
JOHNSON & JOHNSON SERVICES INC.MEDTRONIC
OLYMPUS CORP.ZIMMER BIOMET
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for minimally invasive medical devices was valued at $26.4 billion in 2022. The market is forecast to grow at a compound annual growth rate (CAGR) of 7.6% to reach $41.0 billion in 2028. In this report, the global market is segmented by type and region. By type, the market is segmented into Equipment’s, applications and End users.
Minimally invasive surgeries (MIS) are considered less traumatic than conventional open surgeries because these open surgeries are performed with traditional laparoscopic instruments, which makes them complex. The minimally invasive laparoscopic cameras are generally inserted with small specialized tools through small incisions. The patients tend to recover faster after these procedures with lesser pain when compared with another form of surgery.
The minimally invasive medical devices is covered by application, end-users.
Products segment will dominate the market by the end of 2028.
North America has the highest market share.
  • B Braun
  • Johnson & Johnson
  • Novartis
  • Stryker
  • Medtronic

Analyst Credentials

Kalyani Kottapenta – Assistant Manager, Life Sciences
Kalyani Kottapenta is a research professional with nine years of experience in the life sciences and healthcare industry. Her expertise in qualitative and quantitative market information, including market dynamics like market sizing, advanced excel based market modeling, data analysis, forecasting, company share analysis, and competitive landscape assessment of the medical device industry, developing custom reports. She holds a master’s degree in Microbiology and a bachelor’s in Biotechnology and Chemistry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: The Market for Minimally Invasive Medical Devices145Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market and Technology Background16Free
Chapter- 4: Market Breakdown by Equipment Type5Free
Chapter- 5: Market Breakdown by Application and End User29Free
Chapter- 6: Emerging Technologies10Free
Chapter- 7: Evaluation of the Market Based on Region18Free
Chapter- 8: Patents16Free
Chapter- 9: Competitive Landscape3Free
Chapter- 10: Company Profiles38Free
Published - Nov-2019| Analyst - Andrew McWilliams| Code - HLC051H

Report Highlights

The global market for MIS devices and equipment sales should grow from $21.2 billion in 2019 to $29.9 billion by 2024 with a compound annual growth rate (CAGR) of 7.1% for the period of 2019-2024. 

Report Includes

  • 38 tables
  • An overview of the global markets for minimally invasive medical devices
  • Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Regional dynamics of the market covering Americas, EMRA, APAC and other emerging economies
  • Discussion of current state of minimally invasive surgical devices and equipments, commercialized and pipeline products, regulations and legislations, as well as key industry aspects
  • Examination of vendor landscape and profiles of industry leading players, including B. Braun Aesculap, Fujifim Holdings Corp., Medtronic Ent Inc., Stryker Corp., Olympus Optical Co., Ltd. and Gyrus Acmi Corp.
Published - Jan-2015| Analyst - Andrew McWilliams| Code - HLC051G

Report Highlights

The global market for MIS devices and equipment was about $14.5 billion in 2013. This market reached about $15.4 billion in 2014 and is expected to reach $21.5 billion in 2019, registering a compound annual growth rate (CAGR) of 6.8% for the period 2014-2019.

Report Includes

  • An overview of the global markets for minimally invasive medical devices and instruments.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Historical and current volume and value data for shipments, specified by end user and geographic markets.
  • Evaluation of demographic, economic, and other factors that will drive future demand for minimally invasive devices.
  • Details concerning promising new surgical procedures and products still in the development and testing stage, and assessments of the probability that they will be commercialized successfully in the next five years.
  • Analysis of the potential market for these developmental procedures and products, taking into account the estimated probability that they will be commercialized.
  • A look at the structure of the minimally invasive surgical devices industry (e.g., market shares, concentration, and recent M&A activity).
Published - Jun-2011| Analyst - Andrew McWilliams| Code - HLC051F

Report Highlights

The global market for MIS devices and instruments was worth an estimated $13.4 billion in 2010.  The market is expected to reach $14.4 billion in 2011 and $21.1 billion by 2016, a compound annual growth rate (CAGR) of 7.9% between 2011 and 2016.

Published - Mar-2009| Analyst - Andrew McWilliams| Code - HLC051E

Report Highlights

  • The global market for MIS devices and instruments was worth $14.8 billion in 2008. This should reach $15.8 billion in 2009 and $23.0 billion in 2014, for a compound annual growth rate (CAGR) of 7.8%.
  • The U.S. has the largest share of the market, worth $8.9 billion in 2008 and an estimated $9.5 billion in 2009. This segment is expected to reach $13.6 billion in 2014.
  • Cardiothoracic surgery was the largest application segment for MIS devices and equipment in 2007, representing 70% of the total market. Cardiothoracic surgery was followed in order of size by orthopedic surgery (12%), gastrointestinal surgery (10%) and gynecology (3%).
Published - Jun-2006| Analyst - Andrew McWilliams| Code - HLC051D

Report Highlights

  • The global market for minimally invasive surgery (MIS) devices and instruments was worth an estimated $12 billion in 2005, and is expected to reach $12.9 billion in 2006 and $18.5 billion by 2011, an average annual growth rate (AAGR) of 7.5% between 2006 and 2011. (These figures include catheters, balloons, stents and other devices used in minimally invasive angioplasty.)
  • The U.S. accounted for about 60% of the world market, or $7.2 billion in 2005, and is growing at an AAGR of 7.2%. The U.S. market should reach $7.7 billion in 2006 and $11.0 billion by 2011.
  • Surgical devices (e.g, stents, catheters, guidewires) are the largest product segment of the U.S. minimally invasive surgery market, of which they accounted for about a 69% share in 2005. Monitoring and visualization systems were the second largest segment of the U.S. market in 2005, with an 11% market share, followed by endosurgical instruments (10%), electrosurgical equipment (8%), and robotics (2%). Surgical robots are the fastest-growing equipment /device segment, with an AAGR of 12% between 2006 and 2011, followed by surgical devices, with an AAGR of 8%.
Published - May-2003| Analyst - Andrew McWilliams| Code - HLC051C

Report Highlights

  • Globally, the MIS devices market saw an average annual growth rate (AAGR) of 10% from 1999 to 2002.
  • By 2007, the market should rise to approximately $8.3 billion at an AAGR of 6.6%.
  • The U.S. market represents nearly 60% of the total world market.
  • Market drivers include demographics, epidemiology, new devices.
  • The lack of surgeons opting to train in MIS is a potential constraint on the market.

Related Reports

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Market for Pain Management Drugs and Devices

Published - Dec 2023 | Publisher - BCC Publishing | Code - HLC026G

The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.

The Market for Minimally Invasive Medical Devices

Published - Aug 2023 | Publisher - Kottapenta Sai Ratna Bramara Kalyani | Code - HLC051J

The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.

Recent Reports

Health and Medical Insurance Providers: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC212B

The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.

Prefilled Syringes: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC223B

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
The Market for Minimally Invasive Medical Devices
Sample Report